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Terminal deoxynucleotidyl transferase (TdT) 1 is an enzyme which has the unique
property of polymerizing deoxyribonucleotides onto a primer in the absence of a
template (1-4) . Chang (4) first reported that TdT is present only in the thymus
among various avian and mammalian tissues examined . Her finding was
extended to humans by McCaffrey et al . (5), who found that the enzyme was
restricted to the thymus in normal tissues but was found in peripheral blood
lymphocytes from a patient with acute lymphoblastic leukemia . The specific
association ofTdT with the thymus has led to the suggestion that TdT might act
as a somatic mutator andcould be implicated in the generation of immunological
diversity (6) .
SinceTdT was thought to be restricted to the thymus, its distribution among
thymocytes has been a critical problem . At least two major thymocyte subpopu-
lations have been identified in mice and other animals (7-13) . The major
subpopulation is immunoincompetent, cortisone-sensitive, rich in Thy, TL, Gix,
and Ly antigens, but bears little orno H-2 antigen . The minor subpopulation, on
the other hand, is immunocompetent, cortisone-resistant, rich in H-2 but low in
Thy and Ly antigens, and carries no detectable TL or G, x . Whether the minor
subpopulation is derived from the major one is still debatable (12) .
In this communication we present evidence for two forms of TdT in murine
thymocytes and for their distribution between two thymocyte subpopulations .
Also, the occurrence of TdT in murine bone marrow cells is reported .
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Materials and :Methods
Cell Preparation .
￿
Thymuses removed from 5- to 8-wk old mice (C57BL/6J ; Jackson Laboratories,
Bar Harbor, Maine) were gently pushed through a stainless steel screen (100 mesh, Cistron Corp .,
Elmsford, N.Y .) in Hanks' balanced salt solution (HBSS; Grand Island Biological Co ., Grand
Island,N.Y.) . The cell suspension wasthen filtered through absorbent cotton (Johnson and Johnson,
New Brunswick, N.J .) . Nucleated cells were counted in 3% acetic acid with a hemocytometer . Cell
viability was determined by the exclusion of 0.05% trypan blue .
Extraction ofDNA Polymerases from Tissues and Cells .
￿
Whole thymuses or other tissues were
homogenized in a Waring blender at high setting for2min in the presence ofTEM (0.05M Tris-HCI,
pH 7.7, 1 mM EDTA, 1 mM 2-mercaptoethanol) at 4°C. KCI was immediately added to a final
concentration of 1 .5 M, andTriton X-100 to 0.5%. The homogenate was mixedthoroughly, stirred at
4°C for 2 h, and dialyzed overnight against 100 vol of TEM-50 mM KCI . The dialysate was
centrifuged at 10,000 g for 10 min followed by another 100,000 g centrifugation for 60 min. The final
supernate (S-100) was saved for phosphocellulose chromatography .
Where cells were the starting material they were washed repeatedly in HBSS andresuspended in
TEM. The resuspended cells were subjected to three cycles of rapid freezing and thawing and
thereafter processed in a manner identical to the crude tissue homogenate described above .
Phosphocellulose Chromatography . Phosphocellulose (Whatman P-11) was prepared by the
method of Burgess (14) . The resin was equilibrated with 50 mM KCl in TEMG (TEM-20% glycerol)
and a 0.5 x 12 cm column was prepared . In a typical purification, the S-100 supernate (10 ml) from
1-3 x 10 8 cellswas applied to thecolumn at a flow rate of 0.2 ml/min . Aftera 10 ml wash with 50 mM
KCI in TEMG, thecolumn waseluted with a 60 ml linear gradient of 0.05-1MKCI in TEMG buffer.
Fractions of 0.9 to 1 ml were collected .
Assay ofDNA Polymerases .
￿
All reactions were performed at 37°C for 15-30 min in 0.1 ml with
0.05 M Tris-HCI, pH 8.3 . Reaction mixtures contained 30-jl portions of the phosphocellulose
fractions . Templates, primers, and deoxynucleotide triphosphates were obtained from commercial
sources (15) . Standard mixtures contained one of the following sets of reagents (5) : (a) For terminal
deoxynucleotidyl transferase : oligo(dA), 2 tug ; MnCl z , 0.6 mM ; dithiothreitol (DTT), 2 mM ;
['H]dGTP, 450 pmoles, 2600 cpm/pmol . (b) ForDNA polymerase-a : poly(dC), 1 lAg; poly(dI), 0.5 kg ;
Mg acetate, 4mM ; ['H]dGTP, 450 pmol, 2,600 cpm/pmol . (c) ForDNA polymerase-,B : poly(dA-dT),
2 kg ; Mg acetate, 6mM ; DTT, 6mM ; ['H]dTTP, 400 pmol, 2,300 cpm/pmol ; dATP 20 nmol .
Reactions were terminated and processed as previously described (5) . One unit ofenzyme activity
wasdefined as the amount catalyzing theincorporation of 1 nmol ofdeoxynucleotide monophosphate
into acid-insoluble material per hour . Enzyme units in a given sample were calculated by integrating
the activity in all fractions containing enzyme activity which eluted from phosphocellulose . Specific
activity (enzyme units/10 8 cells) was computed on the basis of nucleated cells . When enzyme activity
was less than four times higher than the background, these fractionswere reassayedby increasing the
reaction volume or using higher specific activity of ['H]dGTP .
Discontinuous Bovine Serum Albumin Density Gradients . Fractionation of mouse thymocytes
was carried out by centrifugation on discontinuous bovine serum albumin (BSA) gradients according
to Dicke et al . (16) . The gradient was prepared by sequentially layering 1-ml portions ofBSA solu-
tions, in 2% decreasing concentration from 35 to 19% into a 16 x 125mm plastic tube (Falcon Plastics,
Div. of BioQuest, Oxnard, Calif.) . The solutions of varying concentrations of BSA were prepared
by diluting astock solution of 35% BSA (Fraction V, Sigma Chemical Co ., St . Louis, Mo .) in 0.15M
Tris buffer (pH 7.2) with sodium phosphate buffer (0.15M NaCl, 0.01 M Na phosphate, pH 7.2) .
The osmolarities of the final solutions were controlled in this wayat 300mOsm/liter . Washed thymo-
cytes (1-4 x 10 8 cells) were suspended in 17% BSAbefore layering this solution on top of the gradient .
The gradient was centrifuged at 1,500 gfor 30 min at 6°C in an International Model PR-J centrifuge
using theno. 269 rotor (International Equipment Corp ., Needham Hts., Mass .) . Cell fractions formed
at the interfaces of neighboring BSA solutions were carefully removed with a Pasteur pipet and
washed in HBSS before cell count and storage at -70°C. Cell fraction 1 was between 17-19% layers,
fraction 2between 19-21% layers etc .
Administration of Cortisone .
￿
C57BL/6J mice (4-8 wk old) were injected intraperitonially with
cortisone acetate (150 mg/kg body weight, Upjohn Co ., Kalamazoo, Mich .) . After the period
indicated as the time of sampling, the mice were chloroformed, exsanguinated by cardiac puncture,
and the thymus removed and suspended in ice-cold HBSS . Contaminating blood vessels andKUNG, SILVERSTONE, MCCAFFREY, AND BALTIMORE
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parathymic lymph nodeswere cleaned away from the thymuses . Theorgans were then processed for
the determination of cell number and the assay ofDNA polymerases . Controlsamples were prepared
using a sterile standard vehicle (Upjohn) .
DNA Polymerases of the Thymus . To characterize the DNA polymerases
from thymus, crude thymic extracts in the high salt buffer were prepared and the
soluble fractions were chromatographed on a phosphocellulose column . The
fractions from the phosphocellulose column were assayed with different template
primers to identify the various DNA polymerases (Fig . 1) . DNA polymerase-a,
Results
Terminal
Deoxynucleotidyl
Transferase
Fraction number
FIG. 1 . Phosphocellulose chromatography of DNA polymerases and terminal transferase
from 1.5 x 10 9 thymocytes . (A) Assays of DNA polymerases . A, polymerase-a assay ; ",
polymerase-,B assay ; O, KCl molarity . (B) Assay of terminal transferase .
which eluted at approximately 0.35 M KC1, was localized using poly(dC) -
poly(dl) . DNA polymerase-0 (the nuclear enzyme) was localized using poly
(dA-dT) as a template-primer and was found to elute at approximately 0.55M
KCl (Fig. 1 A) . 2
TdT eluted from the column before either of the two replicative DNA
polymerases . Two peaks of TdT activity could be detected using oligo(dA) as a
primer anddGTP as a substrate (Fig . 1 B) . The minor peak, called peak 1, eluted
'The nomenclature forDNA polymerases used here was agreed to by a number of workers in the
field during a recent meeting . Publication of its rationale is planned . DNA polymerase-a was
previously called "C" by us while DNA polymerase-,B was previously called "N" (5) .858
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at 0.22 M KCI while the major peak II eluted at 0.29 M KCI. In various
preparations, the elution positions of these two peaks have varied by about 0.02
M KC1 but their separation has been constant . When each of the peaks was
separately pooled and rechromatographed on a phosphocellulose column, each of
them eluted at approximately the same salt concentration as it had originally
(Fig . 2) . Thus there appeared to be two forms of terminal transferase in murine
thymic extracts . Two forms of human TdT have been observed by McCaffrey et
al . (17) using similar methodology . In the thymus ofboth species the later eluting
peak is the predominant one with about 3-10% of the total activity appearing in
peak 1 .
To determine how best to assay murine TdT, all four possible oligonucleotide
primersand all four possible substrates were varied systematically . The results in
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FIG. 2 .
￿
Rechromatography on phosphocellulose of peak I and peak II terminal transferase .
Fractions from the column described in Fig. 1 were pooled, dialyzed against 50 mM
KCI-TEMG, and rechromatographed . (A) 3 ml of pooled fractions from 0.22 M peak in Fig . 1
B . (B) 1 ml of pooled fractions from 0 .29M peak in Fig . 1 B.
Table I indicate that for peak II the most active substrate for polymerization
under our assay conditions was [3H]dGTP and the most active primer was
oligo(dA). Polymerization of dGMP onto any of the four oligomers occurred at a
higher rate than the polymerization ofany other nucleotide . Similarly, polymeri-
zation onto oligo(dA) occurred at a faster rate for all substrates than polymeriza-
tion onto any other primer . No significant unprimed activity was demonstrable .
Results with peak I have been identical . These specificities are similar to those
of human TdT (17) . The specificities differ markedly from those reported for
calf TdT, but the assays in those studies were done under conditions very
different from ours (18) .
Tissue Distribution of TdT in Mice . TdT was originally reported to be
restricted to the thymus (4) . Recently low activities ofTdT have been detected in
bone marrow of healthy human subjects (17, 20) . Although in mice the thymus
has the highest level ofTdT ofany tissue we have assayed, a low specific activity
has also been found in the bone marrow (Table 11) . Other tissues have no
demonstrable activity . The TdT activity in bone marrow elutes from phosphocel-
lulose at the same salt concentration as peak 11 .
TdT in Separated Thymocytes .
￿
Suspensions of thymocytes were prepared byKUNG, SILVERSTONE, McCAFFREY, AND BALTIMORE
TABLE I
Substrate and Primer Preferences of Mouse Terminal
Transferase Peak II
Peak fractions from the phosphocellulose column shown in Fig. 2 B were pooled
and assayed with concentrations of primer and substrate corresponding to those
described for oligo(dA) and dGTP in Materials and Methods. The amount of
substrate incorporated in each case was normalized to the value observed for
oligo(dA) and dGTP, which is taken as 100%.
TABLE II
Tissue Distribution of Mouse Terminal Transferase
Thymocytes (2 x 108 cells), bone marrow (10 x 108 cells), spleen (2.2 x 108 cells),
lymph nodes (0.59 g), brain (1.7 g), liver (6 g), and heart (2.5 g) were assayed in
these experiments. All tissues were collected from 5- to 7-wk old mice. The limit
of the enzyme assay was about 0.02 unit.
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gently pushing whole thymuses through astainless steel screen . More than 98% of
the cells were viable after this treatment as judged by their ability to exclude
trypan blue and most of the TdT activity was recovered in the cell suspension.
The thymocytes were fractionated on a 17-35% discontinuous BSA gradient and
nine cell fractions plus a pellet were obtained. The distribution of cells in the
various fractions is shown in Fig. 3.
To determine the activity of TdT in each of the cell fractions, extracts were
chromatographed on phosphocellulose columns. Fig. 4 A shows the activities of
peak I and peak II in each of the thymocyte fractions. Fraction 5, which
contained 35% of the total thymocytes, had the highest specific activity of peak II
TdT (2.1 U/108 cells) . Both the lighter and heavier fractions had lower activities
with minimal activities in fractions, 1, 2, 3, 8, 9, and the pellet.
The distribution of peak I TdT through the BSA gradient was different from
that of peak II (Fig. 4 A) . The highest specific activities of peak I were found in
the upper fractions (fractions 1, 2, 3) . Detectable levels of TdT peak I were
Substrate
(dA),5 (dC) .
Primer
(dG),5 (dT),6 Unprimed
dATP 1 .8 0 1 .3 0.2 0
dCTP 15 0 1 .7 2 0
dGTP 100 1.6 21 .4 15 0.2
dTTP 7 .5 0.4 4 2 0.1
Enzyme unit/108 cells
Thymus 1.5
Marrow 0.05-0.1
Spleen 0
Lymphnodes 0
Liver 0
Brain 0
Heart 0860 DNA POLYMERASES IN SUBPOPULATIONS OF THYMOCYTES
2 4 6 8 Pellet
Cell fractions
FIG. 3. Fractionation of normal thymocytes and cortisone-resistant thymocytes on BSA gra-
dients. Data are given perthymus, but for normal cells, thymuses from four mice were pooled
and for the cortisone-resistant thymocytes, six mice treated for 24hwith cortisone were L - -,ed .
", Normal ; O, cortisone-treated .
Cell fraction
FIG. 4. Specific activities of terminal transferase and DNA polymerases in thymocytes
fractionated in a BSA gradient . Values are averages of two to three determinations . For each
assay, 0.5-2 x 10 8 cells were pooled from thesame fraction of multiple gradients andassayed .
For purposes of comparison, the DNA polymerase values were normalized to fraction 5 .
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present throughout the rest ofthe gradient.Thus the lowest density fractions had
the highest ratio of peak I to peak II TdT activity.
The amounts ofDNA polymerases-a anda were also determined in the various
fractions from the BSA gradient (Fig. 4 B) . Fractions 1, 2, and 3 had the highest
specific activities of both DNA polymerases.
Effect of Cortisone. To determine whether the cells containing TdT were
sensitive or resistant to cortisone, mice were treated with cortisone and their
thymuses removed at various times thereafter. Fig. 5 shows that the number of
d
0 m
0
a
U
N
0-
-o-e- Cell number
-o-a- Peak I TdT activity
-"--x- Peak II TdTactivity
Hours post-cortisone treatment
FIG. 5. Effect of cortisone on thymocyte numbers and terminal transferase activities. Each
enzyme determination represents assays of 3-6 x 108 thymocytes pooled from as many animals
as necessary. Each point represents the total enzyme activity per animal and is an average of
two determinations.
cells per thymus decreased rapidly after cortisone treatment and the levels of
peak 11 TdT activity decreased even more dramatically. Peak I TdT activity also
fell, initially at a very rapid rate, but after about 15 h a residual level of peak I
activity remained while peak 11 activity declined to almost immeasurable levels.
The elution profiles from phosphocellulose of the TdT activity remaining after
24 and 48 h of cortisone treatment are shown in Fig. 6 A & B. Virtually the only
activity demonstrable by 48 h was peak I.
The data on the effect of cortisone on various DNA polymerase activities is
plotted in Fig. 7 as activity per 108 cells remaining in thethymus at various times
after cortisone treatment. It is evident that the remaining cell populations
change their characteristics. First a population deficient in both TdT activities
and DNA polymerase-a is selected for but after 12 h of cortisone treatment the
cells remaining have increasing levels of peak I TdT and after 36 h they have
increasing levels of DNA polymerases-a and a. Peak II TdT per cell shows a
monotonic decline over 48 h. The cell population remaining 48 h after treatment
is similarto the cells in fractions 1 and 2 from the BSA gradient except that more
TdT peak 11 is present per cell in the least dense normal cells.862
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FIG. 6.
￿
Phosphocellulose chromatography of terminal transferase remaining in thymocytes
after24 or 48 h ofcortisonetreatment . Foreach time point 3 x 10 8 cells were analyzed .
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FIG . 7. Terminal transferase and DNA polymerase activities after cortisone treatment
expressed as specific activity . Data are recalculated from Fig. 5as the specific enzyme activity
per 10 8 remaining nucleated cells after various times of cortisone treatment . The values are
given as percent of untreated thymocytes .
Discussion
It is evident that the mouse thymus contains two forms of TdT which are
distinguishable both by the salt concentration necessary to elute them from a
phosphocellulose column and by their physiology . Peak I TdT shows a higher
specific activity in low density thymocytes than in the bulk of the thymocyte
population and this form of the enzyme is also more resistant to cortisone
treatment than is the major peak II activity (Figs . 4 A, 7 A) . This behavior is
consistent because cortisone causes a less severe depression to the low density
thymocytes than it does to the bulk of the thymic cell population (Fig . 3) .
Although we have not yet been able to find any other biochemical or physical
difference between the two forms of TdT further studies may reveal such
distinctions .KUNG, SILVERSTONE, MCCAFFREY, AND BALTIMORE
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In humans (17), rats (19), and mice (present data) the majority of TdT activity is found in
the major populationof thymocytes which occurs at the center of a BSA gradient. Most of
this TdT activity is peak II in both humans and mice. Cells containingthe highest density
of thymus-specific antigens, such as Thy-1, TL, and Ly, are also localized in the central
region of the density gradient (10). Whether these cells are precursor to mature T cells or
whether they are dead end cells is unclear (12) .
The fraction of cells which contains the highest specific activity of peak I TdT is the
same fraction which is cortisone-resistant. Cells with these properties have previously
been shown to be immunocompetent (7, 8, 10) . However, the light fraction of thymocytes
appears to include two cell populations (12) . The high level of DNA polymerase-a in these
cells along with their higher DNA synthetic activity (9) suggests that cells which are
rapidly multiplying are found in this region of the gradient . From the relatively small
effect of cortisone on DNA polymerase-a activity (Fig. 7 B), it would appear that these
dividing cells are resistant to steroid treatment . The light fraction of cells also includes
cellswhich are immunocompetent, have low amounts of certain thymus-specific antigens,
and are cortisone-resistant (10) . Whether one or both of the two cell pop1hations in the
light region of the BSA gradients contain TdT can only be guessed at present. An
attractive hypothesis is that TdT peak I is the initially synthesized form of the enzyme
and is active in the cortical, dividing cells while peak II is a derivative form of the enzyme
found mainly in the bulk population of denser, cortisone-sensitive and TL+ thymocytes
which may be destined for death. Alternatively, TdT peak I could be restricted to the
immunocompetent thymocytes rather than to the dividing cells but, in that case, the
enzyme must be lost when the immunocompetent cells leave the thymus.
The observation of cells bearing TdT in the mouse bone marrow is in agreement
with recent human studies (17, 20). Are these stem cells destined for the thymus,
or might they instead be B-cell precursors? Further investigation of this cell
population will be necessary to answer this question.
From the foregoing discussion it is evident that TdT may be valuable as a
biochemical marker for studying the differentiation sequence of T cells. The role
of TdT in the physiology of the thymus and bone marrow may become more
evident when the particular cells containing the various forms of the enzyme are
better understood.
Summary
The mouse thymus contains two forms of terminal deoxynucleotidyl transferase
(TdT) which are distinguishable by the salt concentration necessary to elute
them from a phosphocellulose column, by their distribution among the thymo-
cyte subpopulations, and by theirsensitivity to cortisone treatment . In the whole
thymus the later eluting peak (peak II) is the predominant one with about 3-10%
of the total activity appearing in peak I. Both peak I and peak II activities are
most sensitively assayed by the polymerization of dGMP onto an oligo(dA)
primer. The minor population of thymocytes which is less dense and cortisone-
resistant contains a higher specific activity of peak I TdT . The majority of TdT
activity is, however, found in the major population of thymocytes which occurs in
the center region of a bovine serum albumin gradient and is cortisone-sensitive . A
very low level of an activity indistinguishable from peak II TdT activity is also
detected in the mouse bone marrow. Other tissues, such as spleen, liver, heart,
and brain lack detectable amounts of TdT activity .864
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